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Abstract
Plasmodium falciparum malaria episodes may vary considerably in their severity and clinical manifestations. There is good
evidence that host genetic factors contribute to this variability. To date, most genetic studies aiming at the identification of
these genes have used a case/control study design for severe malaria, exploring specific candidate genes. Here, we
performed a family-based genetic study of falciparum malaria related phenotypes in two independent longitudinal survey
cohorts, as a first step towards the identification of genes and mechanisms involved in the outcome of infection. We studied
two Senegalese villages, Dielmo and Ndiop that differ in ethnicity, malaria transmission and endemicity. We performed
genome-scan linkage analysis of several malaria-related phenotypes both during clinical attacks and asymptomatic
infection. We show evidence for a strong genetic contribution to both the number of clinical falciparum malaria attacks and
the asymptomatic parasite density. The asymptomatic parasite density showed linkage to chromosome 5q31 (LOD=2.26,
empirical p=0.0014, Dielmo), confirming previous findings in other studies. Suggestive linkage values were also obtained at
three additional chromosome regions: the number of clinical malaria attacks on chromosome 5p15 (LOD=2.57, empirical
p=0.001, Dielmo) and 13q13 (LOD=2.37, empirical p=0.0014 Dielmo), and the maximum parasite density during
asymptomatic infection on chromosome 12q21 (LOD=3.1, empirical p,10
24, Ndiop). While regions of linkage show little
overlap with genes known to be involved in severe malaria, the four regions appear to overlap with regions linked to
asthma or atopy related traits, suggesting that common immune related pathways may be involved.
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Introduction
Most malaria deaths occur as a consequence of complications
following infection with Plasmodium falciparum. Severe malaria
episodes may vary considerably in the nature of clinical
manifestations, and in the event of death, its precise cause.
Indeed, death may result from severe anaemia, cerebral malaria,
acidosis or multiple organ failure, or a combination of these [1]. In
addition, P. falciparum infection may be an indirect cause of death,
which results from e.g. concomitant septicaemia. The contribution
of host genetic factors to the risk of severe outcome following
infection has long been recognized, with Haldane reporting for the
first time a major role of one genetic variant in the b-globin gene,
the sickle cell mutation (HbS), in the protection against severe
malaria [2]. Since then, b -globin, and several other genes and
genetic variants have been shown to be involved in the protection
or susceptibility to severe malaria, including a-globin, HLA and
several cytokine loci [3]]. Most of the protective variants are
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for malaria as a result of the high selective pressure due to the
parasite [2,4–6]. In most cases, including HbS, the mechanisms
underlying this protection remain unclear, as well as the role of
particular genetic variants in the clinical manifestations of disease.
Most of the genes that have been explored and reported to date
encode red blood cell proteins, proteins involved in the immune
response to infection, or in other pathophysiological mechanisms
directly relevant to malaria infection. These genes have been
identified through case/control association studies, comparing
severe malaria to uncomplicated malaria cases. Such a study
design is limited in four aspects: 1) it has been restricted to the
examination of specific candidate genes, based on their presumed
functional relevance to malaria; 2) it provides little understanding
of the causal role of specific genes and variants; 3) there is
considerable variability among studies, depending on the disease
selection criteria, population background and environmental
context, which may result in poor reproducibility; 4) the severe
vs. mild dichotomy is complex, because the mild malaria group
may include patients who have not developed severe complications
and yet are fully susceptible to severe malaria.
Evidence for a contribution of host genetic factors to phenotypes
related to mild clinical malaria (such as number of clinical
episodes, parasite density, immune responses to P. falciparum
antigens) has been reported in four types of studies: concordance
studies in monozygotic versus dizygotic twins [7], studies of two
African sympatric ethnic groups differing in susceptibility to
malaria [8,9], segregation studies in malaria endemic populations
[10,11] and linkage analysis [12–15]. Several additional studies
have shown association of specific genetic polymorphisms with
clinical malaria [16–19]. However, these previous studies had
limitations in the nature of the phenotypes that were considered
and in the extent of genetic study. There is no clear picture of the
mechanisms of naturally acquired immunity to malaria, and the
relationship of mild to severe malaria is still unclear. Few studies
have examined the genetic contribution to asymptomatic malaria
[12–14,20]. Recently, there has been a first attempt at a genome-
wide linkage study approach that revealed several novel
chromosomal regions linked to clinical and parasitological malaria
traits [15].
In order to gain insight into disease mechanisms and the
biological processes underlying the response to infection, and to
identify the genes and genetic variants controlling these pathways,
we designed a family-based genetic study of phenotypes related to
infection with P. falciparum. This study was carried out in two
independent villages, Dielmo and Ndiop that differ significantly in
malaria transmission intensity and ethnicity in Senegal [21,22].
Transmission in Dielmo is perennial and intense, while it is strictly
seasonal and with a 10-fold lower number of infectious bites/year
in Ndiop, so that exposure to infection and acquisition of
immunity differ in both villages. Furthermore, the population of
each village belongs to different ethnic groups. This study design
enabled us to replicate the extent of genetic influence on malaria
phenotypes identified in one village with the other. We recorded
data related to malaria clinical attacks and asymptomatic
infections for P. falciparum on a longitudinal, uninterrupted basis
for over a decade [21,22]. First, we defined phenotypes relevant to
malaria infection that showed inter-individual variation, and we
estimated the genetic contribution to these phenotypes. We then
selected those phenotypes with significant genetic contribution for
performing family-based genome-wide linkage studies.
This study enabled us to confirm the importance of a previously
identified chromosomal region and identify two novel regions
linked to the occurrence of clinical attacks and one novel region
linked to asymptomatic parasite density.
Results
Family structure and ethnic groups
The entire population of each village was invited to participate
in the study; there were no exclusion criteria. Less than 20%
declined to participate. The majority of DNA samples were
obtained from 3-generation families, though some were available
from 4 generations of the families. The family structures were
established using a questionnaire to the villagers, confirmed and
adjusted by identity by state allele sharing of microsatellite
genome-scan data in each pair of relatives. In each village, the
majority of individuals were related to each other, forming one
large complex family. Family structure statistics for each village are
shown in Table 1. Within the large complex family, there are
many small family units, some of which, because of multiple
marriages, include several half-sibling relationships (sibships).
Therefore, the small family units contained either (a) full-sibships
only (FS), (b) mixed full- and half-sibships (MS), (c) half-sibships
only (HS) or (d) only-child family (OC). Only individuals from
whom we had DNA samples were included in the description of
the family structure. When necessary, virtual individuals, which
include absent or deceased relatives, were created to link the small
family units. DNA samples were obtained from 421 individuals in
Dielmo and 457 individuals in Ndiop. Thus, for the large complex
family in Dielmo, there were 18 FS, 12 MS, 10 HS units and 52
OC, all of which were linked because at least one of the unit
members was a 1
st cousin of someone else in this large complex
family. There were 2 OC that were linked to the large complex
family through a 2
nd cousin relationship and 2 FS units and 8 OC
that were linked because they were uncles or aunts. For the large
complex family in Ndiop, there were 20 FS, 15 MS, 6 HS units
and 24 OC that were linked because at least one of the members
was a 1
st cousin of someone else in this large complex family.
There were 1 OC that was linked to the family through a 2
nd
cousin relationship and 20 OC that were linked because they were
uncles or aunts. In the MS units, the number of FS units varies.
There are more FS units in MS units in Ndiop than Dielmo, which
thus gave a higher number of half sib-pair counts in Ndiop
(Table 1).
In Dielmo, the ethnic groups consisted of 79% Serere
(Niominka: 59% and Sine/Baol: 20%), 11% Mandinka and
10% miscellaneous, whereas in Ndiop, there were 76% Wolof,
19% Fulani and 5% miscellaneous.
Malaria related phenotypes
For each person, the following malaria-related phenotypes were
considered: 1) The number of clinical episodes of P. falciparum
(acronym PFA). This phenotype characterizes the individual
tendency to become clinically ill following P. falciparum infection;
2) The maximum and mean P. falciparum trophozoite parasite
densities (i.e. pathogenic parasite stage infecting red blood cells)
during clinical episodes (acronym mx-PFD and me-PFD, respec-
tively). Maximum density was chosen to assess whether there were
individual human differences in tolerance of parasite burden prior
to onset of clinical symptoms. Because the parasite density eliciting
a clinical reaction may also vary according to the parasite
genotype, we considered a second related phenotype, the mean
density; 3) The prevalence of asymptomatic P. falciparum infection,
which reflects the acquisition of clinical immunity and/or the
tolerance of parasitic infection (acronym PtPF). The acquisition of
non-sterilising clinical immunity occurs with repeated exposure to
Linkage, falciparum Malaria
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influenced by human genetic differences independently of
exposure; 4) The mean and maximum P. falciparum parasite
densities during asymptomatic infection (acronym me-tPFD and
mx-tPFD). These phenotypes are equivalent to those of category 2,
but emphasising the ability of the individual (and human-parasite
interaction) to tolerate parasite density without clinical reactivity.
For each malaria phenotype, we first performed statistical
analyses of the data using multivariate regression analysis to take
into account non-genetic factors such as age, year of study and
transmission intensity (see Materials and Methods). The unex-
plained residual variation for each phenotype per person was then
used for further analyses. As expected, some of the phenotypes
were significantly correlated (Table 2). The residual number of
clinical P. falciparum attacks (PFA) showed a significant positive
correlation with the maximum parasite density during clinical
attacks (mx-PFD) in both villages. It showed a moderate negative
correlation with the mean and maximum parasite density during
asymptomatic P. falciparum infection (me-tPFD and mx-tPFD,
respectively) in both villages, before correction for multiple testing.
Genome scan linkage analysis
We selected phenotypes that showed significant heritability for
further linkage studies (Table 3), namely: number of P. falciparum
clinical attacks (PFA), the mean of parasite density during clinical
attacks (me-PFD), prevalence of asymptomatic infection (PtPF) in
both villages, the mean and the maximum (me-tPFD and mx-
tPFD, respectively) asymptomatic parasite density. The mean
asymptomatic parasite density (me-tPFD) was also studied in both
villages despite the fact that it did not show a significant heritability
in Ndiop, in order to enable comparison with previous studies [12–
14]. The maximum parasite density during clinical attack (mx-
PFD) was only studied in Ndiop because there was no significant
heritability in Dielmo.
Genome scan was carried out using 400 markers with average
interval of 10 cM (Panel MD-10, Applied Biosystems). In addition,
we typed 66 markers localised near candidate genes selected from
studies of severe malaria (marker list available on request). These
candidate genes were selected according to (i) their previous
proposed association with severe malaria (e.g. TNF, NM 000594;
ICAM1, NM_000201; CD36, NM 001001547, NM 001001548
and NM 000072; CR1, NM 000651 and NM 000573), (ii) their
high frequency of mutations known to be common in malaria
endemic region and suspected to be protective (e.g. HBB,
NM_000518; HBA1, NM 000558 and HBA2, NM 000517;
SLC4A1, NM 000342 [AE1 or band 3], G6PD, NM 000402 and
NM 001042351) (iii) their role as a receptor for malaria antigens
(e.g. the glycophorins) and (iv) their immunological response to
malaria infection (e.g. TGFB1, NM 000660; FCGR gene family,
IL10, NM 000572; NOS2A, NM 000625). An average information
content of 0.68 (SD60.12) was achieved at any point of the
genome.
We performed duplicate linkage analyses using the variance
component model (VCM) using SOLAR program [23] (see
Materials and Methods), because of the robustness of this method
in such a complex setting [24], and a regression linkage method
using MERLIN program [25] (Regress, see Materials and
Methods), which yielded overall comparable results. SOLAR
can analyse large complex families such as observed here, while we
modified the large complex family in each village into smaller sized
ones in order to run MERLIN. The results of genome-wide
analysis, using VCM, in the two villages are show in Figure 1 for
Dielmo and Figure 2 for Ndiop. Several regions showed suggestive
evidence of linkage, on the basis of LOD score values .2 with
both VCM and Regress methods. Although several regions did
show LOD score .2 by VCM, this result was not confirmed by
Regress (e.g. Figure 1 Phenotype PFA chromosome 4). Indeed,
only few regions reached such a LOD score value by both methods
in each population studied.
For the number of clinical P. falciparum attacks (PFA), linkage
was detected in two chromosome regions in Dielmo: on
chromosome 5p (near marker D5S419), with LOD scores of
2.57 (empirical p=0.001) and 2.81 (nominal p=2610
24) using
VCM and Regress respectively (Figure 3A) and on chromosome
13q (near marker D13S218), with LOD scores of 2.37 (empirical
p=0.0014) and 2.65 (nominal p=2 610
24) using VCM and
Regress respectively (Figure 3C).




Sex: M/F ratio 1.24 1.11
Age
a median (min-max) yrs
b 16 (0–83) 15 (0–76)
Ethnic groups 79% Serere 76% Wolof
11% Mandinka 19% Fulani
10% miscellaneous 5% miscellaneous
Entomological Inoculation (infected bite/person)
c
Rainy season (June–October) 132.5 23.8
Dry season (November–June) 60.1 0
Family structures




Mean coefficient of inbreeding 0.0008 0.002
Family size: number of individuals (number of families)
453 (1) 503 (1)
35 (1) 17 (1)
30 (1) 14 (1)
22 (1) 13 (3)
11 (1) 12 (2)
14 (2) 11 (2)
8 (1) 9 (1)






Full sib-pair 513 547
Half sib-pair 299 780
Cousin pair 1157 1533
Parent-Child pair 842 924
Grandparent-Nephew pair 884 860
Avuncular pair 773 986
aAge at the first year of study
b0=newborn
cAverage from 1990–99 in Dielmo, 1993–99 in Ndiop
doi:10.1371/journal.pone.0002000.t001
Linkage, falciparum Malaria
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the 5q31 region (near marker D5S436) with the mean transformed
parasite density (me-tPFD) in Dielmo with LOD scores of 2.26
(empirical p=0.0014, VCM) and 2.4 (nominal p=4 610
24,
Regress) (Figure 3A). In Ndiop, linkage to a region of chromosome
12 (near marker D12S351) was detected for the maximum of
trophozoite density (mx-tPFD), with LOD scores of 3.1 (empirical
p,10
24, VCM) and 2.27 (nominal p=7 610
24, Regress)
(Figure 3B). It is interesting to note that although the heritability
of the mean P. falciparum asymptomatic trophozoite density (me-
tPFD) did not reach significance in Ndiop, genome scan linkage
analysis revealed a LOD score of 2.08 (empirical p=0.005) by
VCM and LOD=1.06 (nominal p=0.014) by regression analysis
in the region of the b-globin cluster on chromosome 11p (Figure 2).
Interestingly, there was linkage to the same region of
chromosome 2p with asymptomatic infection that was replicated
in both villages with LOD scores .1. For mean asymptomatic
parasite density (me-tPFD), we obtained LOD=1.68, empirical
p=0.005 in Dielmo (near marker D2S168) and LOD=1.75,
empirical p=0.0009 in Ndiop (near marker D2S319) by VCM in
SOLAR and LOD=2.16, empirical p=0.0009 (near marker
D2S319) when combining the 2 villages. LOD scores were similar
with the maximum asymptomatic parasite density (mx-tPFD). This
was not, however, reproduced when analysing with MERLIN that
can not take into account large complex family structures.
Discussion
The duration of the survey, which is the longest active case
follow-up period to date for a genetic study of malaria [21,22],
allowed us to derive precise, robust phenotypes of clinical and
asymptomatic P. falciparum malaria in both villages. With this study
design, we were able to control for two major confounding factors
of malaria infection rates, namely anti-malarial intake [26] and
transmission intensity [27,28]. Compared to previous linkage
studies of clinical malaria [14,15], our study is on a larger scale,
with respect to the number of subjects and pairs of relatives. We
show here that both clinical and asymptomatic malaria pheno-
types were under genetic control in these populations. This genetic
control includes the number of P. falciparum clinical attacks, P.
Table 2. Correlation of phenotypes
Acronym
a PFA me-PFD mx-PFD PtPF mx-tPFD me-tPFD
NDIOP PFA 0.34 0.54 20.23 20.18 20.21 DIELMO
,0.0001 ,0.0001 0.0009 0.01 0.002
me-PFD 0.05 0.68 20.14 20.04 20.13
0.43 ,0.0001 0.22 0.76 0.26
mx-PFD 0.35 0.64 20.11 20.04 20.13
,0.0001 ,0.0001 0.22 0.68 0.14
PtPF 20.08 20.11 20.06 0.64 0.66
0.15 0.11 0.36 ,0.0001 ,0.0001
mx-tPFD 20.07 20.14 0.03 0.56 0.69
0.27 0.054 0.69 ,0.0001 ,0.0001
me-tPFD 20.12 20.13 20.01 0.63 0.73
0.049 0.08 0.90 ,0.0001 ,0.0001
Regression coefficient shown above and p value below.
Results of Dielmo are shown in the upper right triangle and the results of Ndiop are shown in the lower left triangle. In bold, significance after Bonferoni multiple testing
correction (p,.05), in italic, not significance (p..05) after Bonferroni multiple testing correction (15 hypotheses tested per vilage).
a For phenotype acronym, see Table 3.
doi:10.1371/journal.pone.0002000.t002
Table 3. Estimation of Heritability





Number of clinical falciparum attacks PFA 0.29 (0.0002) 0.27 (0.00002)
Mean parasite density (mean, Log10) me-PFD 0.22 (0.03) 0.21 (0.02)
Maximum parasite density (max. Log10) mx-PFD 0.02 (0.37) 0.13 (0.04)
Asymptomatic infection
P. falciparum trophozoite
Prevalence of asymptomatic PF infection PtPF 0.29 (0.017) 0.35 (0.0001)
Asymptomatic trophozoite density of PF (mean, Log10 +1) me-tPFD 0.33 (0.02) 0.07 (0.28)





PLoS ONE | www.plosone.org 4 April 2008 | Volume 3 | Issue 4 | e2000Figure 1. Genome scan linkage analysis results by the variance component method (SOLAR) in Dielmo, PFA, the number of clinical
episodes of P. falciparum. mxPFD and mePFD, the maximum and mean P. falciparum parasite densities during clinical episodes. PtPF,
the prevalence of asymptomatic P. falciparum infection. metPFD and mxtPFD, the mean and maximum P. falciparum parasite densities during
asymptomatic infection. Vertical dotted lines represent chromosome boundaries, horizontal dotted lines indicate nominal p values corresponding to
LOD score.
doi:10.1371/journal.pone.0002000.g001
Figure 2. Genome scan linkage analysis results by the variance component method (SOLAR) in Ndiop, PFA, the number of clinical
episodes of P. falciparum. mxPFD and mePFD, the maximum and mean P. falciparum parasite densities during clinical episodes. PtPF, the
prevalence of asymptomatic P. falciparum infection. metPFD and mxtPFD, the mean and maximum P. falciparum parasite densities during
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infection. Based on genome-wide linkage analysis, suggestive
evidence of linkage of these traits was detected in four
chromosomal regions, including three novel ones.
In both villages, we found evidence for a strong genetic
contribution to the residual number of P. falciparum clinical attacks
(PFA). The heritability observed confirms previous observations in
cohorts of Kenyan children [10]. It is remarkable that very similar
heritability coefficients were estimated using two distinct study
designs, recruitment procedures and, importantly, very different
definitions of clinical malaria: fever associated with any P.
falciparum density in Kenya [10] and fever associated with high,
age-dependent parasite density in our study [29]. Interestingly, a
strong genetic effect was detected in both villages for the
prevalence of P. falciparum asymptomatic infection (PtPF) and
maximal density of P. falciparum during asymptomatic infection
(mx-tPFD). This suggests a genetic contribution to the control of
peripheral blood parasitaemia. The equivalent measures for
clinical episodes, PFA and mx-PFD, were positively associated
with each other in both villages. This is consistent with the
interpretation that the subjects experiencing many P. falciparum
clinical attacks have a poor capacity to control parasite density,
which frequently reaches the high threshold density necessary to
elicit a clinical attack [29]. On the other hand, there was a
negative correlation between the ability to harbour high parasite
loads without symptoms (mx-tPFD and me-tPFD) and the number
of clinical malaria attacks (PFA). Our results point to a genetic
influence on the control of parasite density governing the
occurrence of clinical attacks. In other words, higher asymptom-
atic parasite loads seemingly protect against occurrence of clinical
episodes. One possible mechanism is through maintenance of an
efficient concomitant ‘‘clinical’’ or anti-disease immunity reducing
the risk of developing clinical malaria despite the presence of a
relatively elevated parasite load. This is the first indication for a
genetic basis to ‘‘premunition’’, a combination of anti-parasite and
clinical immunity acquired by individuals living in endemic areas
[30].
We replicated the finding of linkage of the chromosome 5q31
region to P. falciparum asymptomatic parasite density that has been
previously reported in three independent studies [12–14]. In
Cameroon, Garcia and collaborators have detected suggestive
linkage between 5q31 and malaria blood infection levels in 9
nuclear families [13], while in Burkina Faso linkage and
association have been detected in much larger samples of 34
and 84 nuclear families [12,14]. These results have been replicated
in a malaria mouse model, Plasmodium chabaudi, where one
quantitative trait locus for resistance to malaria has been mapped
in homologous regions of human 5q31-q33 [31]. Compared to
these previous studies, our study is more powerful in two ways.
First the size of our population is higher (190 nuclear families in
Dielmo and 208 in Ndiop). Second, the phenotype that we used
for asymptomatic parasite density was derived from a much larger
number of observations. We have used an average of 34 and 21
measurements per person in Dielmo and Ndiop, respectively while
there were 6 and 20 measurements in Cameroon and Burkina
Faso respectively [12–14]. In addition to malaria, 5q31 locus has
been linked to schistosomiasis [32] and leishmaniasis [33], to
several immune related disorders, including asthma/atopy [34],
some autoimmune diseases such as inflammatory bowel disease
[35], Crohn disease [36], Celiac disease [37] and psoriasis [38]. In
addition, significant linkage to this region was shown in melanoma
risk [39], autism [40] and schizophrenia [41]. This region contains
a cluster of cytokines, which may represent strong candidate genes
for control of malaria infection, but the causative gene(s) and
Figure 3. Detailed linkage analysis results with 2 methods: variance component (SOLAR and MERLIN) and regression (MERLIN); X
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identified. Among these genes, IL12B (NM_002187) seems to play
a critical role since it has been associated with some immune-
related diseases. An insertion/deletion polymorphism in the
promoter region of IL12B has been reported to be associated
with psoriasis [42] and cerebral malaria [43] while two intronic
SNP polymorphisms were associated to asthma [44,45]. However,
we found no evidence of association of this promoter region
polymorphism with the clinical malaria related phenotypes that we
studied (data not shown).
With the exception of the b-globin locus, where we found
suggestive evidence for linkage to some of the selected traits, there
was no overlap of the regions of linkage that we detected and the
location of the genes that have been previously reported to be
associated with severe/cerebral malaria. We also did not find any
evidence for linkage and association of the ICAM-kilifi variant with
PFA and other malaria-related traits in these villages [46]. This
apparent discordance between genes responsible for severe
malaria and those controlling the response to P. falciparum infection
in our study may reflect in part the constraints imposed by either
approach, limited by the study of only selected candidate genes in
previous studies, and limited in the power to detect small effects in
our study. Moreover, variants responsible for susceptibility or
protection against severe malaria, and that have a strong
individual effect, may have a limited impact at the population
level because of low frequency [47], as was suggested for b-globin
in a Kenyan population [10]. The sample size of the populations
studied here and the family structures are such that they are
unlikely to present the entire repertoire of variants for malaria
related genes. In addition, this may also indicate that the
mechanisms (and genes) involved in the protection against severe
malaria are largely independent of those involved in the response
to mild clinical malaria and/or the control of blood parasitaemia.
Overall, genome scan linkage analyses showed peaks with
higher LOD scores in Dielmo than in Ndiop. One reason for this
is that the higher transmission intensity in Dielmo would reduce
individual variation in exposure to infected bites, a major non-
genetic factor. For asymptomatic phenotypes, prevalence (PtPF)
gave lower LOD scores than parasite density (mean or maximum),
although it showed highly significant heritability in Ndiop.
Prevalence is strongly dependent on exposure and thus environ-
mental factors, whereas parasite density will be determined by
host-parasite biological interactions. Further analysis by the
variance component method that included the effect of house
supported this hypothesis: there was a strong effect of house on
asymptomatic prevalence but not parasite density (data not
shown).
We detected suggestive evidence of linkage to malaria-related
traits in three new regions: chromosome 5p15-p13 and 13q13-q22
with the number of P. falciparum clinical malaria attacks (PFA) in
Dielmo, and chromosome 12q21-q23 with the maximum parasite
density during asymptomatic carriage (mx-tPFD) in Ndiop.
Linkage results that we obtained in the two villages were notably
different. This may be related to the important differences both in
the ethnic backgrounds and in the prevailing transmission
conditions in these villages. There was also no overlap between
the regions that we detected in our study and those detected in an
independent genome-wide linkage study of clinical P. falciparum
malaria in Ghana [15]. Again, this may be explained in part by the
different study design, as the Ghana study was restricted to
children less than 12 years old, excluded any individuals with any
of the major haemoglobinopathies (HbS, haemoglobin C, and
alpha+ thalassaemia deletion 3.7) and/or with glucose 6 phosphate
dehydrogenase deficiency A- and involved individuals with a
different genetic background. On the basis of the ‘‘modest’’ value
for linkage and multiple phenotypes under consideration, some of
the regions detected with suggestive linkage in either study may
also correspond to false positive results. Further genome linkage or
association studies in other families and cohorts will be needed to
confirm these initial results.
The three novel regions of suggestive linkage that we identified
harbour a number of genes that can be considered as candidates
for a role in malaria response. These include several genes
involved in innate immunity such as interleukin [interleukin 7
receptor (IL7R, NM_002185)], tumour necrosis factor synthesis
[C1q and tumor necrosis factor related protein 3 (C1QTNF3,
NM_030945 and NM_181435)] and a gene involved in the
complement system (C9, NM_001737). Genes located within these
regions might participate in development of ‘‘clinical’’ immunity.
Among these genes, IL7R (5p13) is implicated in B and T cell
differentiation and is also critical for the innate and adaptive
inflammatory and immunological response [48]. IL7 signalling is
important for T cell differentiation of CD4– CD8– thymocytes
and has a role in survival of CD4+ CD8+ cells after positive
selection [48]. Several genetic and functional studies have
associated genetic variants of IL7R gene with susceptibility to
multiple sclerosis [49-51]. Therefore this gene could be a strong
candidate for malaria infection. On the other hand, it has been
reported that CD8+ T cells induced by Plasmodium yoelii sporozoites
develop into protective memory cells without undergoing changes
in interleukin-7 receptor a expression [52]. However, to date there
has been no association study between IL7R polymorphisms and
malaria, so further studies are needed to assess the implication of
IL7R gene in malaria infection.
It is intriguing to note that these three regions of suggestive
linkage, as well as the 5q31 region, where we replicated previous
suggestive evidence of linkage, have all been previously found to be
linked to asthma/atopic disease or related phenotypes [53–58].
Moreover, a mouse model for human atopic disease (NC/Jic) was
found to be susceptible to murine malaria [59] and a major
quantitative trait locus (derm1) for atopic disease mapped close to
the region controlling parasitaemia (char1 or pymr) on mouse
chromosome 9 [60]. These findings raise the hypothesis that the
development of clinical malaria may be due to an allergic reaction
to malaria parasites or by-products of parasite infection, or that
allergy/atopy and the response to malaria infection may share
common mechanisms [61]. The observation that the number of
clinical malaria attacks decreases with age and cumulative
exposure in endemic areas, whereas the rate of asymptomatic
infection increases, may reflect the development of immunotoler-
ance rather than solely the development of immunoprotection.
‘‘Clinical’’ immunity to malaria may indeed be immunotolerance
and absence of allergic-type responses rather than the presence of
neutralising antibodies to malaria ‘‘toxins’’ as previously suggested
[62,63]. Several lines of evidence support the concept that
susceptibility to malaria and atopy may be related to the same
immunological defect. In Ethiopia, atopic children had a higher
prevalence of malaria attacks [64], while in Tanzania maternal
malaria had a protective effect on wheezing in children age of 4
[65]. The role of IgE in clinical and severe malaria is still poorly
documented and results are controversial. P. falciparum-specific IgE
is elevated in malaria patients and has been proposed to play a
pathogenic role in severe malaria [66–68], whereas, in asymp-
tomatic individuals, it was associated with protection [69]. An
important role of the Th1/Th2 balance in the development of
clinical malaria has been suggested by numerous studies [66].
Our study has limited power, as reflected by the relatively
modest LOD scores. Indeed, similar limitations of linkage
Linkage, falciparum Malaria
PLoS ONE | www.plosone.org 7 April 2008 | Volume 3 | Issue 4 | e2000approaches have been encountered in most studies of multifacto-
rial diseases, even when using much larger numbers of families
[70]. The 10 cM linkage scan in our study provided an average of
70% coverage at any point along the genome. As far as linkage
information is concerned, a slight increase in power could be
gained using a higher density scan. However, this is unlikely to
result in very different conclusions from the present work, which
confirmed one previous reported linkage region and identified
three new ones. On the other hand, much increased power would
be expected using association studies with a higher density scan, as
has been shown before [71]. One of the advantages of the family-
based nature of the study is avoiding spurious association that may
occur as a consequence of the population admixture that prevails
in these villages, and generally in African villages. We are currently
pursuing with a high-density SNP association screening in regions
of linkage detected in this study in order to identify the loci
involved in the control of the falciparum malaria related phenotypes
investigated.
An additional limitation and one shared by all studies and
approaches to date, is the accurate characterisation of disease
phenotypes when dealing with a human population. General
health status of the population, malnutrition and co-infection can
alter the clinical outcome of infection [72,73]. Helminth
infestation in particular is widespread and, in Dielmo, has been
suggested to adversely affect the clinical outcome of malaria
infections [74]. Elimination of helminths can apparently reduce
the risk of severe disease in areas with stable and endemic malaria
[74] but has no such effect in areas of low, unstable transmission
[75,76]. Inclusion of all such confounding factors in our analyses
would require an unworkably complex study design and statistical
analyses.
Our study provided several new and interesting findings, not
only on the genetic basis to disease but also on how human
genetics may influence the biology of the parasite within the host.
We defined relevant malaria related traits and estimated their
genetic contribution, and mapped genes involved in their control.
In addition to replicating linkage to the 5q31, and to some extent
to the b-globin locus, we identified linkage to three additional
regions. While these regions are extensive and contain many
putative candidate genes, it is remarkable that 5q31 and these
three novel regions overlap with regions that have been previously
identified to be involved in asthma/atopy, hence suggesting that
common mechanisms may be involved between both pathogenic
mechanisms. These results will provide highly valuable informa-
tion in the context of integrated studies combining linkage and
high density association studies for various malaria traits and
conditions. Ultimately, these results will help understand the
molecular mechanisms underlying pathogenesis, control of
parasite density, and possibly immunotolerance to malaria




The Dielmo and Ndiop longitudinal surveys have been
described in detail elsewhere [21,22]. The project protocol and
objectives were carefully explained to the assembled village
population and informed consent was individually obtained from
all subjects either by signature or by thumbprint on a voluntary
consent form written in both French and in Wolof, the local
language. Such consent was obtained in the presence of the school
director, an independent witness. For very young children, parents
or designated tutors signed on their behalf. The protocol was
approved by the Ethical Committee of the Institut Pasteur de
Dakar and the Ministe `re de la Sante ´ of Senegal. An agreement
between Institut Pasteur de Dakar, Institut de recherche pour le
de ´veloppement (IRD) and the Ministe `re de la Sante ´e td el a
Pre ´vention of Senegal defines all research activities in Dielmo and
Ndiop villagers. Each year, the project was re-examined by the
Conseil de Perfectionnement de l’Institut Pasteur de Dakar and
the assembled village population; informed consent was individ-
ually renewed from all subjects. DNA samples were obtained from
421 individuals in Dielmo and 457 individuals in Ndiop.
Study sites
Two villages of differing malaria epidemiology were studied.
Malaria transmission is perennial in Dielmo, where a river
maintains larval breeding sites for the mosquitoes. By contrast,
malaria transmission is strictly seasonal in Ndiop and dependent
upon the rainy season that occurs from July-September. Such
differing transmission has marked consequences on the epidemi-
ology of malaria in the villages. This is most evident in the higher
P. falciparum prevalence rates of infection in Dielmo (80+%)
compared to the seasonal rates in Ndiop that change from 20% in
the dry season to 70% in the rainy season [22,77]. Peak incidence
rates of clinical disease due to P. falciparum occur in very young
children (2–5 years old) in Dielmo and then decline rapidly with
age compared to 5–10 years old in Ndiop with only a gradual
decrease with age [78]. The acquisition of non-sterilising clinical
immunity thus generates a much higher prevalence of asymptom-
atic infections in Dielmo. A field research station with a dispensary
was built for the project in each village to identify (and treat) all
episodes of morbidity. Similar entomological surveys and identical
strict clinical surveillance programs were carried out in both
villages. The level of malaria transmission was monitored during
the whole study period. Night-time collections of mosquitoes
landing on volunteer subjects living in Dielmo and Ndiop were
carried out weekly or monthly. It was thus possible to estimate the
entomological inoculation rate (EIR), i.e. the number of infective
bites, for every time period. During the study, Dielmo had a ten-
fold higher EIR than Ndiop (Mann-Whitney p ,0.001).
Malaria related parameters measurement
During the first intensive survey period, malaria parasitaemia
was determined by thick blood film for each inhabitant regardless
of symptoms, twice a week from June to September 1990 in
Dielmo and once a week from July 1993 to January 1994, then
once a month from January to July 1994 in Ndiop. All thick blood
films were examined by reading 200 oil-immersion fields on each
slide (about 0.5 mL of blood) [79]. The ratio of P. falciparum
trophozoites to leukocytes was established. Measures of parasitae-
mia i) during pregnancy and ii) in the three days preceding or
following any fever episode were excluded from the analysis of
asymptomatic parasitaemia. Only individuals with at least six
eligible estimations of parasitaemia were considered.
Following this initial period, only clinical malaria attacks were
recorded. Case detection was both active and passive. A villager,
who had volunteered to participate in the study, was visited daily
at home by a physician, a technician, a nurse or medical field
workers. Thick blood films were prepared and detailed medical
examinations were made for villagers who had fever or any
symptom that could be related to clinical malaria. A standardized
questionnaire was completed for each episode of illness, recording
clinical findings, treatment administered [80] and response to
treatment. None of the inhabitants received antimalarial chemo-
prophylaxis. The justification for not providing chemoprophylaxis
within the project was based on the semi-immune status of the
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permanent presence of a medical team in each village with daily
home visits to each inhabitant. Urine tests were regularly carried
out in the villagers to detect the presence of antimalarial drugs.
Less than 2 percent of the results of tests carried out during the
study period were compatible with unprescribed self-treatment.
We considered an episode of P. falciparum clinical malaria in any
case of fever (axillary temperature .=37.5uC) or fever-related
symptoms (headache, vomiting, subjective sensation of fever)
associated with i) a P. falciparum parasite/leukocyte ratio higher
than an age-dependent pyrogenic threshold previously identified
in the patients from Dielmo [29] or ii) a P. falciparum parasite/
leukocyte ratio higher than 0.3 parasite/leukocyte in Ndiop.
The survey periods were defined by trimester for each
inhabitant. Only person-trimesters with more than 30 days under
survey in the village were included in the analysis. Person-
trimesters with pregnancy during the trimester were excluded.
Transformation of data
Data for each malaria-related phenotype were first analysed
using multivariate regression analysis according to the distribution
of the data. This method enabled us to take into account known
confounding factors such as age, year of study and transmission
intensity. The residual unexplained variation in each phenotype
was then calculated from the difference between the observed and
expected values and then used as the phenotype for further genetic
analysis.
For clinical malaria attacks, we considered the number of
clinical malaria attacks recorded during June 1990 to May 1998 in
Dielmo and during July 1993 to May 1999 in Ndiop. The median
(range) number of clinical P. falciparum malaria attack/person was
1 (0–69) in Dielmo and 2 (0–37) in Ndiop. The residual number of
clinical P. falciparum attacks was transformed from the number of
clinical malaria attacks during person-trimesters separately for
each village by Poisson regression models including the effect of
age, level of transmission and year of survey. To take into account
the malaria exposure dependent acquired immunity in Dielmo,
the models also controlled the effect of the proportion of time
spent in the village for each individual from his/her birth to the
beginning of person-trimester survey period. This confounding
factor had no significant effect in Ndiop. Mean and maximum of
decimal log transformed maximum parasite density during clinical
attacks were analyzed as residuals after accounting for age using
linear regression.
Asymptomatic parasitaemia was evaluated from the systematic
thick blood films collected from each inhabitant during the first
intensive survey period as described above. The median (range)
number of measurements per individual was 33 (6–46) in Dielmo
and 24 (6–34) in Ndiop. Asymptomatic parasitaemia was
considered in two respects, namely prevalence and intensity. For
the prevalence, the residual risk of having a positive blood smear
for trophozoites was estimated. First, the probability of having a
positive slide was separately estimated for trophozoites by logistic
regression models, including variables for the effect of age, week of
sampling and delay between the end of the preceding anti-malarial
treatment and the date of sampling for each thick blood film. For
each individual, the expected number of positive thick blood films
was calculated by the sum of the probabilities estimated by the
models divided by all observations of parasitaemia eligible for
analysis from that individual. An Anscombe residual was then
calculated for each individual as a function of the sum of the
observed and the expected positive thick blood films. Densities
were estimated as the number of trophozoites per 100 leukocytes.
Addition of 1 to the density before decimal logarithm transfor-
mation allowed negative blood films to be taken into account. The
expected parasite density of all thick blood films was estimated by
multiple linear regression analysis controlling for the same
confounding factors as for prevalence. A raw residual was
calculated by subtracting the observed from the expected parasite
density. The mean raw residual was calculated for each individual
and was used as a phenotype for further genetic analyses. In order
to test the maximum capacity of each individual to carry parasites
without symptoms, we considered the maximum parasite density
of all measurements during asymptomatic carriage. We performed
decimal logarithm transformation and controlled for age and week
of study.
The transformed phenotypes were tested for normal distribution
by estimation of skewness and kurtosis and Shapiro-Wilks test for
normality. All phenotype analyses were performed using STATA
version 7.
Microsatellite Genotyping
DNA was extracted from 10 mL venous blood or 0.5 mL
capillary samples and randomly amplified using a primer
extension pre-amplification method [81]. Genotyping of micro-
satellites was carried out using a ABI377 system (Applied
Biosystems, Foster City, USA). Genotyping results were checked
for excess homozygotes or excess heterozygotes assuming Hardy-
Weinberg equilibrium. Markers, which showed excessive homo- or
heterozygosity were re-examined. Mendelian inheritance within
families was confirmed using the PedCheck program [82] and
inconsistencies resolved by re-examination of the raw data and re-
genotyping where necessary. After Mendelian inheritance was
resolved, unlikely genotypes were detected by the program
MERLIN. Suggested microsatellite genotyping errors were
corrected by re-examination of the raw data and re-genotyping
where necessary.
Statistical genetic analysis
Pedigree structures were checked by identity by state allele
sharing of each relative pair from genotyping results of
microsatellite markers used during genome screening using
IBS_check program (Heath, unpublished).
Evaluation of the genetic contribution to the phenotypes was
performed by estimation of the heritability using the variance-
component model [83]. A variance components analysis of family
data decomposes the total variance of the phenotypes into 3
components that are due to genetic (polygenic) (h
2), individual (e
2)
and quantitative trait locus (q
2) effects. First, we tested for
heritability of the phenotype by comparing likelihood between
the reduced model, where total variation is due to environmental
variation only, and the full model where total variation is
composed of environmental and genetic effects estimated from
the genetic relationship of each pair of individuals. When the null
hypothesis was rejected, heritability (h
2) was then estimated as the
percentage of genetic variance of the total.
For phenotypes that showed significant heritability, we
performed linkage analysis to estimate the genetic variance
attributable to the region around a specific genetic marker [83–
86]. We compared the reduced model where total variation is due
to environment and polygenic with the full model that included
the locus specific effect using identity by descent estimation from
the corresponding genetic marker.
Estimation of heritability and linkage analyses were run by use
of the SOLAR program (version 2.1.3). SOLAR can analyse large
complex families such as observed here. The complex family
structure is accounted for in the genetic analysis via the polygenic
variance component that uses the relationship coefficient between
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showed residual kurtosis of more than 0.8, t option, which creates
an extra parameter in the model to describe the distribution of the
phenotype, was applied in all analyses. A general additive model
was used, making no assumption of dominance or recessive nature
of the gene. Empirical p values were obtained by performing a
simulation of 10,000 trials implemented in the SOLAR software
[23,24]. Identity by descent status for each locus was estimated for
the linkage study as a multipoint fashion using Markov Chain
Monte Carlo methods by use of LOKI (version 2.4.5). SOLAR
allows us to include house (shared environment) variance
component in the model by creating a house matrix including
pairs of individuals across the populations, if they are in the same
house, they will be assigned a value of 1 and if not, 0.
In addition to variance component analysis using SOLAR, we
performed regression linkage and variance component analysis
using the MERLIN program [25]. The regression linkage analysis
used a regression-based procedure for linkage analysis that uses
trait-squared sums and differences to predict identity by descent
sharing between any non-inbred relative [87]. In order to run
MERLIN, we modified the large complex family in each village
into smaller sized ones. In the simplified family structure, each
individual will have only 1 sibling relationship. When these
individuals occur in another pedigree, they will be parents or
grandparents of the family without phenotypes.
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